United States Seeks Stay Of Compounded Drug Case Due To Partial Shutdown

Mealey's (January 2, 2019, 1:17 PM EST) -- WASHINGTON, D.C. — The United States on Dec. 28 asked the U.S. District Court for the District of Columbia to stay a lawsuit by two compounded drug companies because the ongoing partial shutdown of the federal government prohibits attorneys for the Justice Department and the Food and Drug Administration from working (Par Sterile Products, LLC, et al. v. Alex M. Azar II, et al., No. 17-2221, D. D.C.)....

Attached Documents

Related Sections